Tripta Bansal

856 total citations
12 papers, 728 citations indexed

About

Tripta Bansal is a scholar working on Oncology, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Tripta Bansal has authored 12 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Pharmaceutical Science. Recurrent topics in Tripta Bansal's work include Drug Transport and Resistance Mechanisms (8 papers), Cancer therapeutics and mechanisms (5 papers) and Drug Solubulity and Delivery Systems (3 papers). Tripta Bansal is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Cancer therapeutics and mechanisms (5 papers) and Drug Solubulity and Delivery Systems (3 papers). Tripta Bansal collaborates with scholars based in India. Tripta Bansal's co-authors include Sushama Talegaonkar, Manu Jaggi, Roop K. Khar, Roop Khar, Roop K. Khar, Gautam Mishra, Naseem Akhtar, Anshumali Awasthi, Gulam Mustafa and Zeenat Khan and has published in prestigious journals such as Life Sciences, Drug Discovery Today and Talanta.

In The Last Decade

Tripta Bansal

12 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tripta Bansal India 11 334 250 176 125 124 12 728
Staffan Tavelin Sweden 13 345 1.0× 293 1.2× 383 2.2× 85 0.7× 67 0.5× 14 1.0k
Brita Sjöström Sweden 13 340 1.0× 333 1.3× 283 1.6× 92 0.7× 80 0.6× 19 912
Luqin Si China 19 249 0.7× 325 1.3× 384 2.2× 193 1.5× 222 1.8× 59 1.2k
Anooshirvan Shayeganpour Canada 14 190 0.6× 244 1.0× 76 0.4× 194 1.6× 67 0.5× 20 822
Bhagwant Rege United States 9 275 0.8× 244 1.0× 509 2.9× 85 0.7× 119 1.0× 12 948
David Dahlgren Sweden 20 435 1.3× 247 1.0× 498 2.8× 76 0.6× 38 0.3× 43 1.1k
Hosnieh Tajerzadeh Iran 14 102 0.3× 240 1.0× 230 1.3× 45 0.4× 83 0.7× 36 792
Abhay T. Sangamwar India 19 163 0.5× 385 1.5× 89 0.5× 121 1.0× 54 0.4× 65 875
Masayuki Akimoto Japan 12 94 0.3× 129 0.5× 169 1.0× 122 1.0× 71 0.6× 39 490
Min-Koo Choi South Korea 10 96 0.3× 143 0.6× 350 2.0× 94 0.8× 116 0.9× 18 680

Countries citing papers authored by Tripta Bansal

Since Specialization
Citations

This map shows the geographic impact of Tripta Bansal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tripta Bansal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tripta Bansal more than expected).

Fields of papers citing papers by Tripta Bansal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tripta Bansal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tripta Bansal. The network helps show where Tripta Bansal may publish in the future.

Co-authorship network of co-authors of Tripta Bansal

This figure shows the co-authorship network connecting the top 25 collaborators of Tripta Bansal. A scholar is included among the top collaborators of Tripta Bansal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tripta Bansal. Tripta Bansal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Bansal, Tripta, Manu Jaggi, Roop Khar, & Sushama Talegaonkar. (2009). Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy. Journal of Pharmacy & Pharmaceutical Sciences. 12(1). 46–46. 197 indexed citations
2.
Bansal, Tripta, Naseem Akhtar, Manu Jaggi, Roop K. Khar, & Sushama Talegaonkar. (2009). Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation. Drug Discovery Today. 14(21-22). 1067–1074. 133 indexed citations
3.
Bansal, Tripta, Manu Jaggi, Roop Khar, & Sushama Talegaonkar. (2009). Status of Flavonols as P-Glycoprotein Inhibitors in Cancer Chemotherapy. Current Cancer Therapy Reviews. 5(2). 89–99. 1 indexed citations
4.
Mustafa, Gulam, Zeenat Khan, Tripta Bansal, & Sushama Talegaonkar. (2009). Preparation and Characterization of Oil in Water Nano-Reservoir Systems for Improved Oral Delivery of Atorvastatin. Current Nanoscience. 5(4). 428–440. 37 indexed citations
5.
Bansal, Tripta, Gautam Mishra, Manu Jaggi, Roop K. Khar, & Sushama Talegaonkar. (2008). Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats. European Journal of Pharmaceutical Sciences. 36(4-5). 580–590. 120 indexed citations
6.
Bansal, Tripta, Anshumali Awasthi, Manu Jaggi, Roop K. Khar, & Sushama Talegaonkar. (2008). Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: Possible contribution of P-glycoprotein. Life Sciences. 83(7-8). 250–259. 61 indexed citations
7.
Bansal, Tripta & Sanjay Garg. (2008). Probiotics: From Functional Foods to Pharmaceutical Products. Current Pharmaceutical Biotechnology. 9(4). 267–287. 22 indexed citations
8.
Bansal, Tripta, et al.. (2008). Solid Self-Nanoemulsifying Delivery Systems as a Platform Technology for Formulation of Poorly Soluble Drugs. Critical Reviews in Therapeutic Drug Carrier Systems. 25(1). 63–116. 37 indexed citations
9.
10.
11.
Panchagnula, Ramesh, Tripta Bansal, Manthena V. S. Varma, & C. L. Kaul. (2005). Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.. PubMed. 60(12). 922–7. 17 indexed citations
12.
Panchagnula, Ramesh, Tripta Bansal, Manthena V. S. Varma, & C. L. Kaul. (2004). Reversed-phase liquid chromatography with ultraviolet detection for simultaneous quantitation of indinavir and propranolol from ex-vivo rat intestinal permeability studies. Journal of Chromatography B. 806(2). 277–282. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Staffan Tavelin Breakdown of academic impact, for papers by Brita Sjöström Breakdown of academic impact, for papers by Luqin Si Breakdown of academic impact, for papers by Anooshirvan Shayeganpour Breakdown of academic impact, for papers by Bhagwant Rege Breakdown of academic impact, for papers by David Dahlgren Breakdown of academic impact, for papers by Hosnieh Tajerzadeh Breakdown of academic impact, for papers by Abhay T. Sangamwar Breakdown of academic impact, for papers by Masayuki Akimoto Breakdown of academic impact, for papers by Min-Koo Choi
Rankless by CCL
2026